Association of Polygenic Score and the Involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder

Lithium is regarded as the first-line treatment for bipolar disorder (BD), a severe and disabling mental disorder that affects about 1% of the population worldwide. Nevertheless, lithium is not consistently effective, with only 30% of patients showing a favorable response to treatment. To provide personalized treatment options for bipolar patients, it is essential to identify prediction biomarkers such as polygenic scores. In this study, we developed a polygenic score for lithium treatment response (Li+PGS) in patients with BD. To gain further insights into lithium's possible molecular mechanism of action, we performed a genome-wide gene-based analysis. Using polygenic score modeling, via methods incorporating Bayesian regression and continuous shrinkage priors, Li+PGS was developed in the International Consortium of Lithium Genetics cohort (ConLi+Gen: N=2,367) and replicated in the combined PsyCourse (N=89) and BipoLife (N=102) studies. The associations of Li+PGS and lithium treatment response - defined in a continuous ALDA scale and a categorical outcome (good response vs. poor response) were tested using regression models, each adjusted for the covariates: age, sex, and the first four genetic principal components. Statistical significance was determined at P<��.

References

Niswender C, Conn P . Metabotropic glutamate receptors: physiology, pharmacology, and disease. Annu Rev Pharmacol Toxicol. 2010; 50:295-322. PMC: 2904507. DOI: 10.1146/annurev.pharmtox.011008.145533. View

Le Clerc S, Lombardi L, Baune B, Amare A, Schubert K, Hou L . HLA-DRB1 and HLA-DQB1 genetic diversity modulates response to lithium in bipolar affective disorders. Sci Rep. 2021; 11(1):17823. PMC: 8426488. DOI: 10.1038/s41598-021-97140-7. View

Schubert K, Thalamuthu A, Amare A, Frank J, Streit F, Adl M . Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. Transl Psychiatry. 2021; 11(1):606. PMC: 8630000. DOI: 10.1038/s41398-021-01702-2. View

Manchia M, Adli M, Akula N, Ardau R, Aubry J, Backlund L . Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report. PLoS One. 2013; 8(6):e65636. PMC: 3686769. DOI: 10.1371/journal.pone.0065636. View

Mercier M, Lodge D . Group III metabotropic glutamate receptors: pharmacology, physiology and therapeutic potential. Neurochem Res. 2014; 39(10):1876-94. DOI: 10.1007/s11064-014-1415-y. View

Ge T, Chen C, Ni Y, Feng Y, Smoller J . Polygenic prediction via Bayesian regression and continuous shrinkage priors. Nat Commun. 2019; 10(1):1776. PMC: 6467998. DOI: 10.1038/s41467-019-09718-5. View

Matosin N, Fernandez-Enright F, Frank E, Deng C, Wong J, Huang X . Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia: implications for novel mGluR-based therapeutics. J Psychiatry Neurosci. 2014; 39(6):407-16. PMC: 4214875. DOI: 10.1503/jpn.130242. View

Southam L, Gilly A, Suveges D, Farmaki A, Schwartzentruber J, Tachmazidou I . Whole genome sequencing and imputation in isolated populations identify genetic associations with medically-relevant complex traits. Nat Commun. 2017; 8:15606. PMC: 5458552. DOI: 10.1038/ncomms15606. View

Thomas P, Campbell M, Kejariwal A, Mi H, Karlak B, Daverman R . PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003; 13(9):2129-41. PMC: 403709. DOI: 10.1101/gr.772403. View

10.

Sanacora G, Zarate C, Krystal J, Manji H . Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008; 7(5):426-37. PMC: 2715836. DOI: 10.1038/nrd2462. View

11.

Amare A, Schubert K, Baune B . Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry. EPMA J. 2017; 8(3):211-227. PMC: 5607053. DOI: 10.1007/s13167-017-0112-8. View

12.

Arning L, Kraus P, Valentin S, Saft C, Andrich J, Epplen J . NR2A and NR2B receptor gene variations modify age at onset in Huntington disease. Neurogenetics. 2005; 6(1):25-8. DOI: 10.1007/s10048-004-0198-8. View

13.

de Leeuw C, Mooij J, Heskes T, Posthuma D . MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015; 11(4):e1004219. PMC: 4401657. DOI: 10.1371/journal.pcbi.1004219. View

14.

Amare A, Schubert K, Hou L, Clark S, Papiol S, Heilbronner U . Association of Polygenic Score for Schizophrenia and HLA Antigen and Inflammation Genes With Response to Lithium in Bipolar Affective Disorder: A Genome-Wide Association Study. JAMA Psychiatry. 2017; 75(1):65-74. PMC: 5833535. DOI: 10.1001/jamapsychiatry.2017.3433. View

15.

McCarthy S, Das S, Kretzschmar W, Delaneau O, Wood A, Teumer A . A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet. 2016; 48(10):1279-83. PMC: 5388176. DOI: 10.1038/ng.3643. View

16.

Amare A, Schubert K, Hou L, Clark S, Papiol S, Cearns M . Association of polygenic score for major depression with response to lithium in patients with bipolar disorder. Mol Psychiatry. 2020; 26(6):2457-2470. DOI: 10.1038/s41380-020-0689-5. View

17.

Blacker C, Lewis C, Frye M, Veldic M . Metabotropic glutamate receptors as emerging research targets in bipolar disorder. Psychiatry Res. 2017; 257:327-337. DOI: 10.1016/j.psychres.2017.07.059. View

18.

Chesney E, Goodwin G, Fazel S . Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry. 2014; 13(2):153-60. PMC: 4102288. DOI: 10.1002/wps.20128. View

19.

CADE J . Lithium salts in the treatment of psychotic excitement. Med J Aust. 1949; 2(10):349-52. DOI: 10.1080/j.1440-1614.1999.06241.x. View

20.

Itokawa M, Yamada K, Iwayama-Shigeno Y, Ishitsuka Y, Detera-Wadleigh S, Yoshikawa T . Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans. Neurosci Lett. 2003; 345(1):53-6. DOI: 10.1016/s0304-3940(03)00501-9. View